Physiological Effects of Drugs: Clinical Trials

11 trials for Physiological Effects of Drugs, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 unknown, 1 recruiting. 11 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 411Completed 8, Unknown 2, Recruiting 1

Follow Physiological Effects of Drugs: new trials by email Literature Review of Physiological Effects of Drugs trials Research Report on Physiological Effects of Drugs

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex
Neostigmine, Sugammadex - Urinary Retention Postoperative, Laparoscopic Cholecystectomy
Phase 4CompletedUniversity of Texas Southwestern Medical Center2352023-09-112024-10-09
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
VTS-K - Treatment Resistant Depression, Major Depressive Disorder
Phase 4CompletedTheresa Jacob, PhD, MPH152022-12-062026-04-21
Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial
Azithromycin 1 gram IV, Cefazolin and indomethacin - Preterm Birth, Obstetric Labor, Premature
Phase 4UnknownThomas Jefferson University502021-12-202023-06-26
Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
Guanfacine Extended Release, Placebo - Prader-Willi Syndrome, Aggression
Phase 4CompletedMaimonides Medical Center152020-12-172024-08-19
Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients
Dexmedetomidine Hydrochloride Group - Delirium, Cognitive Dysfunction
Phase 4RecruitingSunnybrook Health Sciences Centre24002019-12-012025-12-01
Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI
Dydrogesterone Oral Tablet, Micronized progesterone, Placebo Dydrogesterone oral tablet - Infertility, Female, Infertility
Phase 4CompletedCRG UZ Brussel302019-05-012020-12-17
Antidiabetic Drugs for Steatotic Liver Disease
Pioglitazone, Empagliflozin, Combination of pioglitazone and empagliflozin - MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Type 2 Diabetes
Phase 4CompletedYonsei University512018-12-062025-03-05
Acceptable Hemodynamic Changes in Dexmedetomidine for Single Intravenous Bolus Injection
Dexmedetomidine - Delirium, Postoperative Complications
Phase 4UnknownSecond Affiliated Hospital of Wenzhou Medical University422018-05-232019-09-25
Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy
Abdominal wall block with liposomal bupivicaine - Pain, Postoperative, Analgesics, Opioid
Phase 4CompletedUniversity of California, Los Angeles1462018-01-012022-01-10
Determination of Minimum Effective Volume of Local Anesthetic in Patients Undergoing Ultrasound-Guided Infraclavicular Approach for Brachial Plexus Blockade
Procedure/Surgery: bupivakain % 0,5 - Underdosing of Local Anesthetics, Anesthetics, Local
Phase 4CompletedAnkara City Hospital Bilkent482015-11-012021-10-27
Memantine for Corticosteroid-Induced Mood and Declarative Memory Changes
Memantine - Physiological Effects of Drugs
Phase 4CompletedUniversity of Texas Southwestern Medical Center202006-03-012008-01-25

Narrower conditions

Delirium (2)  ·  Mental Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurobehavioral Manifestations (2)  ·  Neurocognitive Disorders (2)  ·  Neurologic Manifestations (2)  ·  Pathologic Processes (2)  ·  Abnormalities, Multiple (1)  ·  Aggression (1)  ·  Agnosia (1)  ·  Behavioral Symptoms (1)  ·  Chromosome Disorders (1)  ·  Cognition Disorders (1)  ·  Cognitive Dysfunction (1)  ·  Confusion (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (4)  ·  Behavior (3)  ·  Neurologic Manifestations (3)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Mental Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurobehavioral Manifestations (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Urogenital Diseases (2)  ·  Aberrant Motor Behavior in Dementia (1)  ·  Abortion, Habitual (1)  ·  Abortion, Spontaneous (1)

Interventions

Dexmedetomidine (2)  ·  Aspirin (1)  ·  Cefazolin (1)  ·  Dydrogesterone (1)  ·  Guanfacine (1)  ·  Indomethacin (1)  ·  Ketamine (1)  ·  Memantine (1)  ·  Neostigmine (1)  ·  Pioglitazone (1)  ·  Progesterone (1)  ·  Sugammadex (1)  ·  Utrogestan (1)  ·  empagliflozin (1)

Sponsors

University of Texas Southwestern Medical Center (2)  ·  Ankara City Hospital Bilkent (1)  ·  CRG UZ Brussel (1)  ·  Maimonides Medical Center (1)  ·  Second Affiliated Hospital of Wenzhou Medical University (1)  ·  Sunnybrook Health Sciences Centre (1)  ·  Theresa Jacob, PhD, MPH (1)  ·  Thomas Jefferson University (1)  ·  University of California, Los Angeles (1)  ·  Yonsei University (1)

Countries

United States (6)  ·  Belgium (1)  ·  Canada (1)  ·  China (1)  ·  South Korea (1)

Top investigators

Deepan Singh, MD (1)  ·  Herman Tournaye, PhD, MD (1)  ·  Jenani S Jayakumaran, MD (1)  ·  Jun Li (1)  ·  Rupsa Boelig, MD (1)  ·  Sherwood Brown, Ph.D., M.D. (1)  ·  Siamak Rahman, MD (1)  ·  Stephen Choi, MD,MSc,FRCPC (1)  ·  Theresa Jacob, PhD, MPH (1)  ·  Tiffany Moon, MD (1)

Results publications

PMID 18582848, PMID 33849856, PMID 34184312, PMID 40336058, PMID 41135925, PMID 41789933

NIH funding

2018 (1)